Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1161-1163
Published online before print June 11, 2009, doi: 10.1161/ATVBAHA.109.187898
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/8/1161    most recent
ATVBAHA.109.187898v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shagdarsuren, E.
Right arrow Articles by Zernecke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shagdarsuren, E.
Right arrow Articles by Zernecke, A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1161.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Importance of Junctional Adhesion Molecule-C for Neointimal Hyperplasia and Monocyte Recruitment in Atherosclerosis-Prone Mice–Brief Report

Erdenechimeg Shagdarsuren; Yassin Djalali-Talab; Michel Aurrand-Lions; Kiril Bidzhekov; Elisa A. Liehn; Beat A. Imhof; Christian Weber; Alma Zernecke

From the Institute for Molecular Cardiovascular Research (IMCAR) (E.S., Y.D.-T., K.B., E.A.L., C.W., A.Z.), RWTH Aachen University, Germany; UMR891, Inserm (M.A.-L.), Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, France; the Department of Pathology and Immunology (B.A.I.), University Medical Centre, Geneva, Switzerland; and the Rudolf-Virchow-Center (A.Z.), DFG-Research-Center for Experimental Biomedicine, University of Würzburg, Germany.

Correspondence to Dr Alma Zernecke, MD, Institut für Molekulare Herz-Kreislaufforschung, Universitätsklinikum der RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany. E-mail azernecke{at}ukaachen.de

Objective— Although junctional adhesion molecule (JAM)-C has been implicated in the control of inflammatory leukocyte recruitment, its role in neointima formation after arterial injury has not been elucidated.

Methods and Results— In apolipoprotein E–deficient (Apoe–/–) mice fed an atherogenic diet, antibody blockade of JAM-C significantly reduced neointimal hyperplasia after wire injury of carotid arteries without altering medial area and decreased neointimal macrophage but not smooth muscle cell (SMC) content. An increased expression of JAM-C was detected in colocalization with luminal SMCs 1 day after injury and neointimal SMCs after 3 weeks. Blocking JAM-C inhibited monocytic cell arrest and leukocyte adhesion to carotid arteries perfused ex vivo and in vivo. Furthermore, monocyte adhesion to activated coronary artery SMCs under flow conditions in vitro was diminished by blocking JAM-C.

Conclusions— Our data provide the first evidence for a crucial role of JAM-C in accelerated lesion formation and leukocyte recruitment in atherosclerosis-prone mice.

We here show that junctional adhesion molecule (JAM)-C antibody blockade reduced neointimal hyperplasia after arterial injury and leukocyte adhesion to carotid arteries. Our data provide the first evidence for a crucial role of JAM-C in accelerated lesion formation and leukocyte recruitment in atherosclerosis-prone mice.


Key Words: leukocyte recruitment • adhesion molecules • remodeling • inflammation • restonosis • atherosclerosis